Hypertension, antihypertension medication, risk of psoriasis

Women with long-term high blood pressure (hypertension) appear to be at an increased risk for the skin condition psoriasis, and long-term use of beta (β)-blocker medication to treat hypertension may also increase the risk of psoriasis.

Psoriasis is an immune-related chronic disease that affects about 3 percent of the U.S. population. The authors suggest prospective data on the risk of psoriasis associated with is lacking. Antihypertensive medications, especially β-blockers, have been linked to psoriasis.

Authors analyzed physician-diagnosed psoriasis in a group of 77,728 who were part of the Nurses' Health Study from 1996 to 2008. Authors identified a total of 843 incident cases of psoriasis.

Women with hypertension for six years or more were at a higher risk for developing psoriasis compared with women with . The risk of psoriasis also was higher both among women with high blood pressure who did not take medication and among women with who did use medication compared with women with normal . A higher risk for psoriasis was found among women who regularly used β-blockers for six years or longer. No association was found between other antihypertensive medications and the risk of psoriasis.

"These findings provide novel insights into the association among hypertension, antihypertensive medications and psoriasis. However, further work is necessary to confirm our findings and clarify the biological mechanisms that underlie these associations." Shaowei Wu, M.D., Ph.D., of Brown University, Providence, Rhode Island, and colleagues wrote in their JAMA Dermatology article.

In a related commentary, April W. Armstrong, M.D., M.P.H., of the University of Colorado, Denver, writes: "A critical practice gap exists in identifying the causes of psoriasis flares, especially medication-related causes. Some physicians may not consistently examine medications for their contribution to psoriasis flares. However, a careful consideration of the role of medications in psoriasis exacerbation may improve long-term control."

More information: JAMA Dermatology. Published online July 2, 2014. DOI: 10.1001/jamadermatol.2013.9957
JAMA Dermatology. Published online July 2, 2014. DOI: 10.1001/jamadermatol.2014.1019

add to favorites email to friend print save as pdf

Related Stories

Skin care tips for psoriasis patients

Aug 25, 2013

(HealthDay)—Sun protection is among the skin care habits that can help people with the chronic skin condition psoriasis reduce some of the discomfort they may experience, such as skin itching, cracking ...

Coffee, caffeine not linked to psoriasis in U.S. women

Mar 21, 2012

(HealthDay) -- Coffee and caffeine are not associated with psoriasis incidence after adjustment for smoking, according to a research letter published in the March issue of the Archives of Dermatology.

Recommended for you

Global Ebola toll rises to 5,689: WHO

2 hours ago

The World Health Organization said Thursday that the global death toll from the Ebola virus had increased to 5,689 out of a total of 15,935 cases of infection, mainly in western Africa.

Ebola vaccine promising in first human trials

13 hours ago

Researchers say they're a step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

At one month, US Ebola monitors finding no cases

16 hours ago

The U.S. program that requires weeks of monitoring for travelers from African countries with Ebola reaches the one-month mark Thursday. And so far, no cases of the disease have turned up.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.